TAF15 (formerly TAFII68) is a member of the FET (FUS, EWS, TAF15) family of RNA-and DNA-binding proteins whose genes are frequently translocated in sarcomas. By performing global gene expression profiling, we found that TAF15 knockdown affects the expression of a large subset of genes, of which a significant percentage is involved in cell cycle and cell death. In agreement, TAF15 depletion had a growth-inhibitory effect and resulted in increased apoptosis. Among the TAF15-regulated genes, targets of microRNAs (miRNAs) generated from the onco-miR-17 locus were overrepresented, with CDKN1A/p21 being the top miRNAstargeted gene. Interestingly, the levels of onco-miR-17 locus coded miRNAs (miR-17-5p and miR-20a) were decreased upon TAF15 depletion and shown to affect the post-transcriptional regulation of TAF15-dependent genes, such as CDKN1A/p21. Thus, our results demonstrate that TAF15 is required to regulate gene expression of cell cycle regulatory genes post-transcriptionally through a pathway involving miRNAs. The findings that high TAF15 levels are needed for rapid cellular proliferation and that endogenous TAF15 levels decrease during differentiation strongly suggest that TAF15 is a key regulator of maintaining a highly proliferative rate of cellular homeostasis.
INTRODUCTION

TAF15 (formerly TAF
68) is a nuclear protein known to associate with a distinct subpopulation of transcription factor IID (TFIID), a multi-subunit complex that nucleates the pre-initiation complex on the promoters of on protein-coding genes.
1,2 As TAF15 was not found to be associated with all human TFIID complexes and has no ortholog in other non-vertebrate species, TAF15 is not considered a canonical TAF. 3 TAF15 harbors a transcriptional activation domain, a RNA recognition motif and many Arg-Gly-Gly (RGG) repeats known to participate in RNA binding.
1 TAF15 together with the related FUS and EWS constitutes the FET (FUS/EWS/TAF15) protein family whose genes are frequently translocated in sarcomas and rare hematopoietic and epithelial cancers. 4 In each case, the N-terminus of the proteins, containing a potent transcriptional activation domain, 5 is fused to the DNA-binding domain of a transcription factor to form oncogenic chimeras. 6 FET proteins have been involved in both transcriptional and post-transcriptional regulatory processes of gene expression, such as transcription initiation, splicing, DNA repair and RNA maturation. 6, 7 However, to date the majority of studies have focused on the functions of FUS and EWS and their aberrant products, but the role of TAF15 in various cellular metabolisms remains unclear. Recently, we showed that a chromatin-associated fraction of TAF15 associates with a human U1 small nuclear RNA. 8 Thus, we hypothesized that the U1-TAF15 particle is produced by remodeling of the canonical U1-snRNP, further suggesting a possible role of TAF15 in additional steps of RNA metabolism. Moreover, an interesting link between FET proteins and miRNAs has emerged. miRNAs are 21-to 24-nucleotide-long RNA guides that regulate the expression of target mRNAs containing complementary sequences. 9 In animals, miRNA genes are typically transcribed into primary transcripts (pri-miRNA) that undergo processing by the Drosha-containing complex Microprocessor. Proteomic studies uncovered that TAF15, together with FUS and EWS, is a subunit of the Microprocessor complex. 10 Moreover, the regulation of a group of miRNAs by the aberrant EWS/Fli protein uncovered a novel mechanism controlling Ewing's sarcoma malignancy via miRNAs. 11, 12 At present, the physiological functions of the wild-type FET proteins, especially that of TAF15, are not well understood, and no cellular genes regulated by TAF15 have been identified. In this study, we show that TAF15 depletion has a growth-inhibitory effect and increases apoptosis of HeLa cells. By combining TAF15-dependent transcriptome analysis with in silico-based miRNA studies, we identified a subset of miRNA targets among TAF15-regulated genes. Indeed, we found that TAF15 is required for the expression of some of the members of the onco-miR-17 family and that its depletion leads to miRNA-mediated upregulation of a target reporter in vivo. Thus, we describe a TAF15-dependent gene regulatory network and show that TAF15 is regulating a subset of the cellular transcriptome and protein levels via miRNAs.
RESULTS
Genome-wide analysis of TAF15-regulated genes
To gain insight into the function of TAF15 in human cells, we performed gene expression profiling upon TAF15 knockdown by RNA interference (Figure 1a) . As a control for off-target effects, we first generated a stable HeLa GL3 cell line expressing the luciferase gene (Supplementary Figure 1a) . These cells were transfected in triplicates with small interfering RNAs (siRNAs) directed either against the luciferase mRNA (si-LUC), to eliminate off-target effects mediated by siRNA transfection, or against TAF15 (si-TAF15) mRNA. TAF15 silencing was specific, as the si-TAF15 had no effect on luciferase activity and efficient at B90% ( Supplementary  Figures 1a and b and Figure 1a) . Total RNA purified from si-TAF15 or si-LUC cells was then used to probe an oligonucleotide-based microarray coding for 26 880 genes. We found that 1628 (7.15%) genes were significantly differently expressed in the two conditions (Figure 1b , Supplementary Table 1) : 721 genes were upregulated and 907 were downregulated in si-TAF15 versus si-LUC samples. Real-time quantitative PCR analysis confirmed the upregulation (BTG2, FGG) or downregulation (TAF15, TTP1, POLR3B) of genes selected among the 10 most affected genes in each category (Figure 1c ). In the downregulated category, we have also validated CDK6 because of its involvement in cell cycle regulation.
A Gene Ontology (GO) study performed with the Ingenuity (IPA) tool assigned the TAF15-regulated genes to a wide set of cellular functions spanning from small molecule biochemistry to protein synthesis and nucleic acid metabolism. However, those genes involved in cell cycle (n ¼ 140; P-value: 2.09 Â 10 À 8 -4.63 Â 10 À 3 ) and cell death (n ¼ 276; P-value: 3.79 Â 10 À 7 -4.63 Â 10 À 3 ) regulation were the most highly represented group identified ( Figure 1d ) together with the cell growth and proliferation category, which was also statistically significant (P-value: 6.9 Â 10 À 5 -4.63 Â 10
; Figure 1d ). The GO analysis revealed an enrichment of genes regulating the G1/S checkpoint (P-value: 4.14 Â 10 À 3 ; Supplementary Figures 2a and b) when the distribution within GO categories was compared with the distribution of the whole set of genes represented on the array (Supplementary Figure 2a) . Thus, human TAF15 can both positively and negatively regulate gene expression, and its depletion influences a high proportion of genes involved in cell cycle transition and cell death. To investigate whether TAF15 affects viability and cell cycle kinetics in vivo, we counted the number of cells at different time points after siRNAs treatment (Figure 2b) . At 72 h post transfection, si-TAF15-treated cells showed a 1.4-fold decrease in their proliferation rate when compared with control si-LUC cells. These results were also confirmed by the measurement of the electrical impedance of si-LUC-and si-TAF15-transfected HeLa cells (Supplementary Figure 3a) . To further study the cell proliferation-inhibitory effects of TAF15 knockdown in another cancerderived cell line, we repeated the above TAF15 depletion and cell counting experiment using the SH-SY5Y human neuroblastoma cell line (Supplementary Figure 3b) . Similarly to HeLa cells, 72 h post transfection, si-TAF15-treated cells showed an about twofold decrease in their proliferation rate when compared with control si-LUC cells.
To verify the specificity of TAF15 silencing and to exclude offtarget effects, we rescued TAF15 in the knockdown cells by overexpressing a TAF15 fusion protein refractory to RNA interference. To this end, we cloned the TAF15 cDNA, lacking its 3 0 -untranslated region (UTR), in the pDendra2-C expression vector knockdown performed with the Ingenuity software. The analysis identified the biological functions and/or diseases that were most significant to the TAF15-regulated genes data set. Bars indicate the top 24 molecular and cellular processes (P-value o2.0 Â 10 À 4 ) in decreasing order of significance. Right-tailed Fisher's exact test was used to calculate a P-value determining the probability that each biological function and/or disease assigned to that data set is due to chance alone. The default threshold (dashed red line) for statistically significant enrichment is 1.3. under the control of a cytomegalovirus promoter. Because of the presence of the Dendra2-tag (26 kDa), the overexpressed Dendra2-TAF15 protein was fully distinguishable from the endogenous TAF15 by western blot analysis (Figure 2a and Supplementary  Figure 3c ). We then designed two siRNAs (si-TAF15-2 and si-TAF15-3, Supplementary Figure 3d ) to target TAF15 at the level of the 3 0 UTR. Transfection of HeLa cells with si-TAF15-3 0 UTR (a mixture of the two 3 0 UTR siRNAs) led to a depletion comparable to that obtained with si-TAF15 (Figure 2a) . Importantly, as observed for the original si-TAF15-treated cells, a decrease in the proliferation rate also occurred when a mixture of the two 3 0 UTR siRNAs was used to deplete TAF15 (Figure 2b ). Under those conditions, the overexpression of Dendra2-TAF15, refractory to the 3 0 UTR siRNAs (Figure 2a) , rescued the viability of the transfected cells (Figure 2b ), demonstrating the specificity of TAF15 knockdown in counteracting cell proliferation.
Next, we performed flow cytometry analysis to distinguish between cell proliferation defects and induction of cell death caused by TAF15 depletion. In TAF15-depleted cells, we observed an increase in the proportion of cells in G1/G0 phase from B55 to B73% at 48 h after transfection, and a decrease of G2 (B17 to B9%) and S (B28 to B18%) phase cells (Figure 2c ) demonstrating a cell cycle defect. Almost 40% of the particles had sub-2N DNA content, suggesting that many of the TAF15-depleted cells underwent apoptosis. Indeed, the Annexin V-fluorescein isothiocyanate (FITC) and the non-vital dye propidium iodide (PI) simultaneous staining revealed an increase of late apoptotic/ necrotic cells upon TAF15 depletion (Figure 2d ). Thus, our findings together demonstrate a novel role for the wild-type TAF15 protein in the maintenance of cell proliferation by counteracting apoptosis in vivo.
TAF15-dependent genes encode validated targets for miRNAs
In an attempt to determine how TAF15 regulates gene expression, we further analyzed the subset of TAF15-regulated genes for increased probability of alternative splicing, alternative terminal exon usage, alternative promoter usage and/or miRNAs targeting. Because of the hypothesized role of TAF15 in splicing and transcription, we first used the FAST DB database 13 to inspect TAF15-regulated genes for the presence of cassette exons, alternative terminal exons, alternative donor/acceptor splicing sites, intron retention or alternative promoters ( Supplementary  Figures 4a-f ). The P-values associated to most of these tested parameters were not statistically significant and only a slight enrichment of genes having at least two alternative promoters was found between TAF15-regulated genes versus nonregulated genes (Supplementary Figure 4f) .
We next analyzed both the entire list of TAF15-dependent genes (data not shown) and the TAF15-dependent genes in each GO category (assigned by IPA; see above) to find miRNA targets. Among the web-based algorithms developed to predict miRNA target genes we used the miRTarBase, 14 which contains the largest set of experimentally verified miRNA:target interactions. By crossing the miRNA targets data set ( Figure 3a ) with the TAF15-regulated genes belonging to the above IPA categories (Figure 3a) , we found that 75 (13%) TAF15-regulated genes encode for validated miRNA targets, with again most of them belonging to cell growth and proliferation, cell death and cell cycle categories. In addition, we found that the TAF15-regulated genes CDKN1A and VEGFA were present in many IPA categories, with CDKN1A being the top miRNAs-targeted gene (31 different miRNAs were described; Figure 3b ). Interestingly, when the 3 0 UTRs of the 75 genes were scanned to define the top targeting miRNAs, the recurrence of validated target sites for the members of the onco-miR-17 family was particularly high, with miR-17-5p and miR20a target sites being the most enriched across all GO categories ( Figure 3c and Table 1 ), followed by the miR-21 and miR-34a, which were also frequent. The recurrence of these target sites together with the preponderance of onco-miR-17 family targets among the TAF15-regulated genes lead us to hypothesize that post-transcriptional control exerted by the onco-miR-17 family might contribute to the gene expression changes observed upon TAF15 knockdown. Figure 3 . TAF15-dependent genes encode transcripts that are overrepresented in validated targets for miRNAs. (a) Venn diagram was generated by overlapping two sets of genes: the first data set (miRTarBase) contains the human miRNA target genes (n ¼ 757) as extracted from the miRTarBase; the second data set (TAF15-regulated genes) contains the TAF15-regulated genes (n ¼ 555) belonging to the first 24 IPA categories. The intersecting region (colored in red) illustrates the number of TAF15-regulated genes for which experimentally validated miRNA:target interactions (MTIs) have been described. (b) Summary heat map of the most represented TAF15-regulated genes for which experimentally validated MTIs have been described. Rows represent IPA and random categories, columns represent miRNAs-targeted genes. Red/white represents high/low content, respectively, of miRNA-validated target sites in the 3 0 UTR of the represented genes. (c) Summary heat map of the most represented miRNAs for which experimentally validated MTIs have been described for the TAF15-regulated genes. Rows represent IPA and random categories, columns represent the targeting miRNAs. Red/white represents, respectively, high/low content of miRNAs-targeting sites. To analyze whether the expression of miRNAs belonging to the onco-miR-17 family were affected following TAF15 depletion, we transfected HeLa cells with two different siRNA mixtures (si-TAF15 and si-TAF15-3 0 UTR). Under both knockdown conditions, TAF15 expression was reduced efficiently (Figures 4b and e) . By northern blot analysis of total RNA (Figure 4a and Supplementary  Figure 5a) , we found that the levels of miR-17-5p and miR-20a decreased significantly under the two different knockdown conditions. We then tested whether the levels of miR-93, miR106a, miR-106b and miR-20b were also affected by TAF15 knockdown. Whereas miR-106a and miR-20b were almost undetectable in HeLa cells (data not shown), the levels of both miR-93 and miR-106b were not influenced by TAF15 depletion, highlighting the specificity of TAF15 in the regulation of the hsamiR-17-92 cluster (Figure 4a ). The changes in miR-17-5p and miR-20a levels could not be attributed to different levels of Microprocessor as the expression of DROSHA and DGCR8 was unaffected by the transfection of TAF15 siRNAs (Figure 4b) . No significant change of mature miR-1 level was measured (Figure 4a ), further indicating that Microprocessor was equally functional in both si-TAF15 and si-LUC conditions. As validated miR-21 and miR-34a target sites were also frequent among the TAF15 genes repertoire (Figure 3c ), we determined whether their levels were altered by TAF15 depletion. We found that the miR-21 and miR-34a were slightly increased (B20%) under TAF15 knockdown, although the mature miR-34a was hardly detectable by northern blot (Supplementary Figures 5b and c) . Thus, our data show that TAF15 knockdown affects the levels of miRNAs belonging to the onco-miR-17 family. Note that a nuclear extract depleted of TAF15 was as competent in pri-miRNA processing of the hsa-miR-17-92 cluster to pre-miRNAs as the control extract (Supplementary Figure 5d) , suggesting that TAF15 does not have a role in post-transcriptional regulation of hsa-miR-17-92 levels.
To shed light on the mechanism by which TAF15 regulates the biosynthesis of those miRNAs produced by the hsa-miR-17-92 cluster (Figure 4c ), we next investigated whether the levels of the pri-hsa-miR-17-92 transcript, were affected under si-TAF15 conditions. To this end, transcripts originated from the pri-hsa-miR-17-92 locus were quantified by reverse transcription quantitative PCR at different positions in wild-type-and TAF15-depleted cells (Figure 4c ). Pri-hsa-miR-17-92 transcript levels decreased upon TAF15 depletion, suggesting an involvement of TAF15 in hsamiR17-92 biosynthesis before its nuclear processing.
TAF15 regulates gene expression through miRNAs Our in silico approach predicted a number of onco-miR-17 family targets among the TAF15-regulated genes, for which CDKN1A was the top miRNA-targeted gene. CDKN1A/p21 is a key regulator of cell cycle and cell death as increased expression of CDKN1A/p21 inhibits cell cycle progression. 16 Furthermore, targeting of the CDKN1A/p21 transcript by miR-17-5p, miR-20a/b, miR-106a/b and miR-93 has been shown to increase cell proliferation and accelerate G1/S transition. [17] [18] [19] The weak increase of CDKN1A/p21 mRNA upon TAF15 depletion (Supplementary Table S1 ) was confirmed by reverse transcription-quantitative PCR analysis (Figure 4d ). However, when CDKN1A/p21 protein levels were measured using two siRNA mixtures against TAF15 (Figures 4e and f) , the increase was twofold higher than the mRNA. The same effects were observed using the SH-SY5Y human neuroblastoma cell line (Supplementary Figure 6) . On the basis of our results showing that the lack of TAF15 (i) upregulates CDKN1A/p21 protein levels and (ii) downregulates miR-20a and miR-17-5p expression, both of which regulate CDKN1A/p21 at the post-transcriptional level, 19 we hypothesized that a miRNAs-dependent post-transcriptional control contributes to increase CDKN1A/p21 expression in TAF15-depleted cells. To test our hypothesis, HeLa cells were treated with siRNAs against either TAF15 or a scramble (si-SCR) siRNA. After 24 h, cells were further transfected with a reporter plasmid carrying the luciferase gene fused to the wild-type 3 0 UTR of CDKN1A/p21 (Figure 5a ). As the endogenous promoter was absent from the reporter, 20 this assay allowed us to measure the post-transcriptional mechanisms regulating CDKN1A/p21 expression without the influence of potential transcriptional regulation driven by the CDKN1A/p21 promoter. In the presence of a wild-type CDKN1A/p21 3 0 UTR, TAF15 depletion significantly increased luciferase expression (Figure 5a ). To further prove that the observed post-translational effects are indeed miRNAmediated, first a reporter plasmid carrying mutations in the onco-miR-17 family seed 20 was used in the luciferase assay (Figure 5b ). The mutation that disrupts the seed abrogates TAF15-mediated upregulation of the CDKN1A/p21-3 0 UTR reporter, CDKN1A hsa-miR-106a, hsa-miR-106b, hsa-miR-125a-5p, hsa-miR-132, hsa-miR-17, hsa-miR-208a, hsa-miR-208b, hsa-miR20a, hsa-miR-20b, hsa-miR-28-5p, hsa-miR-298, hsa-miR-299-5p, hsa-miR-302a, hsa-miR-345, hsa-miR-363, hsamiR-372, hsa-miR-423-3p, hsa-miR-503, hsa-miR-515-3p, hsa-miR-519b-3p, hsa-miR-519d, hsa-miR-519e, hsa-miR520a-3p, hsa-miR-520b, hsa-miR-520h, hsa-miR-572, hsamiR-639, hsa-miR-654-3p, hsa-miR-657, hsa-miR-93, hsamiR-96
VEGFA hsa-miR-106a, hsa-miR-106b, hsa-miR-107, hsa-miR-126, hsa-miR-134, hsa-miR-140-5p, hsa-miR-147, hsa-miR-150, hsa-miR-15a, hsa-miR-15b, hsa-miR-17, hsa-miR-195, CDK6 hsa-miR-20a, hsa-miR-20b, hsa-miR-302d, hsa-miR-361-5p, hsa-miR-372, hsa-miR-373, hsa-miR-383, hsa-miR-504, hsa-miR-520g, hsa-miR-520h, hsa-miR-93 hsa-let-7b, hsa-miR-107, hsa-miR-124, hsa-miR-137,hsamiR-16, hsa-miR-185, hsa-miR-203, hsa-miR-29a, hsamiR-29b, hsa-miR-29c, hsa-miR-30a*, hsa-miR-34a, hsamiR-34b, hsa-miR-34b*, hsa-miR-424, hsa-miR-449a, mmu-miR-124, mmu-miR-137
CCND1 hsa-let-7b, hsa-miR-106b, hsa-miR-15a, hsa-miR-16, hsamiR-16-1*, hsa-miR-17, hsa-miR-193b, hsa-miR-19a, hsamiR-20a, hsa-miR-302a, hsa-miR-302c, hsa-miR-34a, hsamiR-424, hsa-miR-449a, hsa-miR-503
MYC hsa-let-7a, hsa-let-7g, hsa-miR-145, hsa-miR-17, hsa-miR20a, hsa-miR-24, hsa-miR-34a, hsa-miR-34b, hsa-miR34b*, hsa-miR-34c-5p, hsa-miR-378, hsa-miR-98
BCL2L11 hsa-miR-17, hsa-miR-181a, hsa-miR-19a, hsa-miR-19b, hsa-miR-25, hsa-miR-32
WEE1 hsa-miR-106b, hsa-miR-17, hsa-miR-195, hsa-miR-20a, hsa-miR-424, hsa-miR-503
E2F3 hsa-miR-125b, hsa-miR-128, hsa-miR-195, hsa-miR-34a, hsa-miR-34c-5p
CDKN1B hsa-miR-128, hsa-miR-181a, hsa-miR-221, hsa-miR-222
SMAD4 hsa-miR-18a, hsa-miR-26a, hsa-miR-483-3p
YES1 hsa-miR-145, hsa-miR-17, hsa-miR-519a
miRNA validated target sites (miRTarbase)
Abbreviations: CCND1, cyclin D1; CDK, cyclin-dependent kinase; miRNAs, microRNAs; VEGFA, vascular endothelial growth factor A. List of miRNAs targeting the TAF15-regulated genes represented in Figure 3a , as extracted from the miRTarbase. The most represented miRNAs, predicted from our analysis (Figure 3b ), are highlighted in red. A full colour version of this table is available at the Oncogene journal online.
TAF15 regulates cell cycle and proliferation M Ballarino et al demonstrating that TAF15 regulates CDKN1A/p21 protein levels through miR-20a-and miR-17-5p-targeting sites. Second, transfection of HeLa cells with a mixture of miR-17-5p/miR-20a locked nucleic acids, significantly increased the CDKN1A/p21 protein levels ( Figure 5c ). Taken together our data show that TAF15 functions by regulating the expression of a subset of genes through miRNAs.
Endogenous TAF15 levels are downregulated during neuronal differentiation miRNAs belonging to the onco-miR-17 family are downregulated during a retinoic acid (RA)-induced differentiation of neuroblasts.
21
In addition, the miR-20a and miR-17-5p downregulation abolishes the growth of neuroblastoma cells through CDKN1A/p21 upregulation. 20 As the artificial reduction of TAF15 levels in HeLa cells (Figures 4a and e-f) resembled the same effects, we wanted to evaluate whether the expression of endogenous TAF15 was altered during two different neuronal differentiation model systems. To this end, human neuroblastomaderived SK-N-BE and SH-SY5Y cell lines were induced to differentiate into late neuronal cells by RA treatment for several days, and TAF15 levels were tested by western blot analysis (Figures 6a and b) . In the SK-N-BE and SH-SY5Y cell lines, RA has been shown to inhibit neuroblastoma cell growth and to promote 22,23 Thus, we used either anti-N-MYC or anti-VGF antibodies to confirm the progressive decrease of cell proliferation in the two cellular systems, respectively (Figure 6a ). In agreement with the above experiments, endogenous TAF15 levels decreased during neuronal differentiation, in parallel with the increase of CDKN1A/p21 protein levels (Figure 6a) . Furthermore, in both cellular systems the endogenous miR-17-5p and miR-20a levels also decreased during differentiation (Figure 6b) . Thus, the fact that in the two cellular differentiation systems used, the decrease of endogenous TAF15 is accompanied by the decrease of miR-20a and miR-17-5p and the consequent increase of endogenous CDKN1A/p21 (Fontana et al. 20 and our study) further demonstrates the physiological significance of our findings. 
DISCUSSION
Three recent studies reported the existence of different miRNAs as targets of the oncogenic EWS-Fli1 fusion protein. 13, 14, 24 According to these findings, the repression of let-7a and the induction of hsamiR-17-92 cluster by EWS-Fli1 participate in the tumorigenic potential of Ewing's sarcoma. In addition, miR-34a has recently been identified as a predictor of prognosis of Ewing's sarcoma patients. 25 Overall, these studies highlighted the importance of miRNAs on post-transcriptional regulation of gene expression in sarcomas. However, before understanding how oncogenic fusion proteins regulate miRNA biosynthesis, it is important to understand how their normal forms are involved in these processes.
Because of the initial identification of TAF15 as a component of at least a specialized subgroup of transcription machinery, and also because of its suggested involvement in chromatin-associated premRNA splicing, 7 we analyzed Pol II transcription following the downregulation of this factor. TAF15 ablation did not result in a general defect in mRNA transcription, but rather in the alteration of the transcription of a specific subset of genes (B1600 genes). These findings confirmed the crucial importance of TAF15 in gene regulation and suggested a variety of possibilities by which TAF15 could orchestrate specific biological programs. Indeed, we found that under normal growth conditions TAF15 controls cellular viability through the regulation of cell cycle and cell death-related genes and a specific subset of miRNAs. The presence of miRNA targets among the TAF15-regulated transcripts together with the impairment of miR-17-5p and miR-20a accumulation in TAF15-depleted cells constitute a novel regulatory pathway of posttranscriptional interactions. Indeed, we show for the first time in different cellular systems that the CDKN1A/p21 onco-miR-17 family connections are also regulated by TAF15 (Figure 6c) .
The fact that upon TAF15 depletion pri-hsa-miR-17-92 transcript levels decreased, suggests for the first time an involvement of TAF15 in the transcription of the human cluster. As the Microprocessor subunit levels were not affected and as TAF15 is not required for efficient processing of the before pri-miRNAs to pre-miRNAs in vitro, it is likely that TAF15 exerts its effect upstream of the nuclear processing of DROSHA-DGCR8.
By using high-throughput sequencing technologies coupled to crosslinking and immunoprecipitation (photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation), the RNA targets of FET family proteins have been recently described. 26, 27 Interestingly, two TAF15-binding sites were detected on the transcript encoded from MIR17HG locus. This finding, together with our results, would suggest a role for TAF15 in regulating hsa-miR-17-92 transcript biogenesis before its nuclear processing. In addition, the photoactivatableribonucleoside-enhanced crosslinking and immunoprecipitation study also showed that a large fraction (47%) of the binding sites for TAF15 fell within intronic regions of RNAs, which is consistent with the hypothesized role of the TAF15 in pre-mRNA maturation and/or stability. Recently, a compact globular tertiary structure has been described for miRNAs encoded by the hsa-miR-17-92 cluster. Interestingly, those pre-miRNAs (that is, miR-20a) that are located within the core of the tertiary structure are less efficiently processed. 28 The fact that TAF15 is mostly required for miR-20a biosynthesis suggests that TAF15 may be differentially required in respect to the tertiary structure of the cluster.
Our studies also support a role for TAF15 in cell proliferation. Porcine FET expression is higher in less differentiated neuronal cell populations and declines during neuronal maturation, in particular TAF15 expression decreases during embryonic development of the hippocampus. 29 In human cells, FET expression is attenuated in differentiating human embryonic stem cells and during induced differentiation of neuroblastoma cells, and is absent in terminally differentiated melanocytes and cardiac muscle cells (Anderrson MK et al. 30 and this study). The fact that endogenous TAF15 levels decrease during differentiation, and that high TAF15 levels are needed for rapid cellular proliferation, strongly suggests that TAF15 is a key factor in the maintenance of a highly proliferative rate of cellular homeostasis. Deregulation of the physiological differentiation-driven reduction of TAF15 by the generation of oncogenic fusion proteins by chromosomal translocations may therefore result in the maintenance of highly proliferative cells that can be at the origin of the corresponding cancers.
Our findings on the function of wild-type TAF15 constitute a good basis for understanding how the TAF15 oncogenic fusion proteins affect gene expression. As chromosomal translocations are necessary, but not sufficient, to produce the pathological phenotype, 31 it is still uncertain whether the gene fusions are sufficient for sarcomagenesis. In this context, alteration of the function of a wild-type form of TAF15 could reinforce the defects produced by the translocated form and eventually lead to a more severe phenotype. 24 Because of their structural resemblance, the possibility that overlapping sets of mRNAs and miRNAs can be regulated by the FUS, EWS, TAF15 proteins can now be further studied.
MATERIALS AND METHODS
Cell culture and treatments
HeLa cells were grown in Dulbecco's modified Eagle's medium medium supplemented with 5% fetal calf serum and antibiotics. The GL3 stable cell line was generated by infecting HeLa cells with a lentivirus expressing the GL3 luciferase gene under the control of a phosphoglycerate kinase promoter (multiplicity of infection ¼ 10). SK-N-BE cells were cultured in RPMI, 10% fetal bovine serum, 1 Â L-glutamine and antibiotics and induced to differentiate by 10 mM all-trans-RA (Sigma-Aldrich, Saint-Quentin Fallavier, France). SH-SY5Y were cultured in RPMI w/o 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10% fetal bovine serum and antibiotics and induced to differentiate by 1 mM all-trans-RA (Sigma). 
Plasmid construction
The Dendra2-TAF15 construct was made by PCR amplification (see Supplementary Table 2 ). The amplification product was inserted into the pDENDRA2-C vector (Evrogen, Moscow, Russia). Pri-17-92 plasmid encoding the pri-hsa-miR17-92 cluster was kindly provided by JF Caceres, 
Microarray analysis and data mining
A 25 000-gene human oligonucleotide microarray was used for transcriptome analysis. 25 Four biological replicates, each si-RNA, were treated in parallel. Total RNA (200 ng) was amplified by PCR, labeled and purified using Nucleospin Extract columns (Masherey-Nagel SARL, Hoerdt, France). After hybridization and slide scanning, (ScanArray4000; PerkinElmer, Coutabeuf, France) the raw data were extracted from images using Imagene5 (BioDiscovery, El Segundo, CA, USA) and the intra-slide normalization performed using the Quantile method adapted to bicolors microarrays. The normalized log2 ratios sample/reference was directly used to compare the 8 different RNA samples. A Student's test was applied to remove nonsignificant genes (P-value ¼ 0.05). A 1.5 absolute fold change and a P-valueo0.05 were chosen as cutoff for statistical significance. To reduce false positives due to background oscillations or saturated signals, only the genes whose average signal intensities (log2) was over 6 and below 13 were qualified. A Westfall and Young resamplingbased P-value adjustment was used for error control in multiple testing. The estimated false discovery rate was 11%. GEO accession number: GSE34470. Molecular and cellular functions and pathway analyses TAF15 regulates cell cycle and proliferation M Ballarino et al were generated using IPA software (Ingenuity Systems, http:// www.ingenuity.com, version: 8.8), which assigned the 1628 TAF15-regulated genes to 74 categories; the top 24 categories are represented in Figure 1d . For miRNA-target analysis, the list of human-validated miRNA:target interactions was extracted from the hsa_MTI.xls file (miRTarBase, database release 2.5). We obtained 1424 rows (links between miRNA-target gene) containing 757 unique target genes and 264 unique miRNAs. The number of target genes was then checked both in the set of TAF15-regulated genes and in each of the 24 IPA categories (n ¼ 555 unique genes) and compared with random selections of 200 genes. For random selection, numbers 1-26 880 were assigned to genes as they appear in the list of the microarray and a Matlab function, which generates uniformly distributed pseudorandom numbers on the open interval (0, 1) was used. The process was repeated 50 times and the indexed gene lists was then selected in each case for analysis.
Northern blot analysis
Five microgram of total RNA was analyzed as already described. 32 Oligonucleotides complementary to mature miRNAs, 5S and 5.8S rRNAs were 32 
